By Neuroscience News
A recent study indicates that nicotinamide riboside (NR), a common form of vitamin B3 found in dietary supplements, may escalate the risk of critical illnesses, such as cancer.
Researchers discovered that an overabundance of NR could intensify the probability of contracting triple-negative breast cancer and its subsequent spread to the brain.
To analyze the extent of NR in cancer cells, T cells, and healthy tissues, the researchers utilized an innovative imaging method reliant on ultra-sensitive bioluminescent imaging.
Researchers anticipate these discoveries could contribute to the creation of inhibitors that might boost the effectiveness of cancer treatments.